Kestra Medical Technologies, Ltd.
Quality Scores
AI Summary
Kestra Medical Technologies (KMTS) is at an early commercialization stage within the wearable medical technology sector, specifically focused on cardiac monitoring via its ASSURE Wearable Cardioverter Defibrillator (WCD). The operational data for FY2025 reveals a business currently characterized by heavy cash consumption and significant net losses as it attempts to scale and establish market share. While the top-line reflects an emerging revenue base of $59.81M, the operating structure is currently heavily loss-making with an operating loss exceeding $100M. The business is fundamentally in a…
Top Opportunities
- Secured 59.8M in revenue indicating commercial traction
- Significant asset base of 295M for a medical tech firm
- Active in high-value Cardiac monitoring/tech sector
Top Risks
- Deeply negative Net Income (-113.8M)
- High cash burn with CFO at -77.6M
- Operating losses significantly exceed total revenue
Latest report: Read the annual report summary →
Earnings update: Read the AI earnings call summary →
Unlock the full report
Full sections, financial charts, AI chat and PDF export are available with Premium.